Global Penpulimab Injection Market Growth 2024-2030

November 2024 | 77 pages | ID: G66FC559F3D7EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Penpulimab Injection is the only new and differentiated PD-1 monoclonal antibody in the world that uses IgG1 subtype and Fc segment modification, which can more effectively enhance the efficacy of immunotherapy and reduce adverse reactions. It is used in the treatment of lung cancer, lymphoma, nasopharyngeal cancer, liver cancer, stomach cancer and other major diseases, and clinical studies have shown superior safety and efficacy.

The global Penpulimab Injection market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Penpulimab Injection Industry Forecast” looks at past sales and reviews total world Penpulimab Injection sales in 2023, providing a comprehensive analysis by region and market sector of projected Penpulimab Injection sales for 2024 through 2030. With Penpulimab Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Penpulimab Injection industry.

This Insight Report provides a comprehensive analysis of the global Penpulimab Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Penpulimab Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Penpulimab Injection market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Penpulimab Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Penpulimab Injection.

United States market for Penpulimab Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Penpulimab Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Penpulimab Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Penpulimab Injection players cover Akeso, Inc, etc. In terms of revenue, the global two largest companies occupied for a share nearly

% in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Penpulimab Injection market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• 100mg (10mL)/Bottle
• Other

Segmentation by Application:

• Lung Cancer
• Lymphoma
• Nasopharyngeal Carcinoma
• Liver Cancer
• Gastric Cancer

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Akeso, Inc

Key Questions Addressed in this Report

What is the 10-year outlook for the global Penpulimab Injection market?

What factors are driving Penpulimab Injection market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Penpulimab Injection market opportunities vary by end market size?

How does Penpulimab Injection break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Penpulimab Injection Annual Sales 2019-2030
  2.1.2 World Current & Future Analysis for Penpulimab Injection by Geographic Region, 2019, 2023 & 2030
  2.1.3 World Current & Future Analysis for Penpulimab Injection by Country/Region, 2019, 2023 & 2030
2.2 Penpulimab Injection Segment by Type
  2.2.1 100mg (10mL)/Bottle
  2.2.2 Other
2.3 Penpulimab Injection Sales by Type
  2.3.1 Global Penpulimab Injection Sales Market Share by Type (2019-2024)
  2.3.2 Global Penpulimab Injection Revenue and Market Share by Type (2019-2024)
  2.3.3 Global Penpulimab Injection Sale Price by Type (2019-2024)
2.4 Penpulimab Injection Segment by Application
  2.4.1 Lung Cancer
  2.4.2 Lymphoma
  2.4.3 Nasopharyngeal Carcinoma
  2.4.4 Liver Cancer
  2.4.5 Gastric Cancer
2.5 Penpulimab Injection Sales by Application
  2.5.1 Global Penpulimab Injection Sale Market Share by Application (2019-2024)
  2.5.2 Global Penpulimab Injection Revenue and Market Share by Application (2019-2024)
  2.5.3 Global Penpulimab Injection Sale Price by Application (2019-2024)

3 GLOBAL BY COMPANY

3.1 Global Penpulimab Injection Breakdown Data by Company
  3.1.1 Global Penpulimab Injection Annual Sales by Company (2019-2024)
  3.1.2 Global Penpulimab Injection Sales Market Share by Company (2019-2024)
3.2 Global Penpulimab Injection Annual Revenue by Company (2019-2024)
  3.2.1 Global Penpulimab Injection Revenue by Company (2019-2024)
  3.2.2 Global Penpulimab Injection Revenue Market Share by Company (2019-2024)
3.3 Global Penpulimab Injection Sale Price by Company
3.4 Key Manufacturers Penpulimab Injection Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Penpulimab Injection Product Location Distribution
  3.4.2 Players Penpulimab Injection Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR PENPULIMAB INJECTION BY GEOGRAPHIC REGION

4.1 World Historic Penpulimab Injection Market Size by Geographic Region (2019-2024)
  4.1.1 Global Penpulimab Injection Annual Sales by Geographic Region (2019-2024)
  4.1.2 Global Penpulimab Injection Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Penpulimab Injection Market Size by Country/Region (2019-2024)
  4.2.1 Global Penpulimab Injection Annual Sales by Country/Region (2019-2024)
  4.2.2 Global Penpulimab Injection Annual Revenue by Country/Region (2019-2024)
4.3 Americas Penpulimab Injection Sales Growth
4.4 APAC Penpulimab Injection Sales Growth
4.5 Europe Penpulimab Injection Sales Growth
4.6 Middle East & Africa Penpulimab Injection Sales Growth

5 AMERICAS

5.1 Americas Penpulimab Injection Sales by Country
  5.1.1 Americas Penpulimab Injection Sales by Country (2019-2024)
  5.1.2 Americas Penpulimab Injection Revenue by Country (2019-2024)
5.2 Americas Penpulimab Injection Sales by Type (2019-2024)
5.3 Americas Penpulimab Injection Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Penpulimab Injection Sales by Region
  6.1.1 APAC Penpulimab Injection Sales by Region (2019-2024)
  6.1.2 APAC Penpulimab Injection Revenue by Region (2019-2024)
6.2 APAC Penpulimab Injection Sales by Type (2019-2024)
6.3 APAC Penpulimab Injection Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Penpulimab Injection by Country
  7.1.1 Europe Penpulimab Injection Sales by Country (2019-2024)
  7.1.2 Europe Penpulimab Injection Revenue by Country (2019-2024)
7.2 Europe Penpulimab Injection Sales by Type (2019-2024)
7.3 Europe Penpulimab Injection Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Penpulimab Injection by Country
  8.1.1 Middle East & Africa Penpulimab Injection Sales by Country (2019-2024)
  8.1.2 Middle East & Africa Penpulimab Injection Revenue by Country (2019-2024)
8.2 Middle East & Africa Penpulimab Injection Sales by Type (2019-2024)
8.3 Middle East & Africa Penpulimab Injection Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Penpulimab Injection
10.3 Manufacturing Process Analysis of Penpulimab Injection
10.4 Industry Chain Structure of Penpulimab Injection

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Penpulimab Injection Distributors
11.3 Penpulimab Injection Customer

12 WORLD FORECAST REVIEW FOR PENPULIMAB INJECTION BY GEOGRAPHIC REGION

12.1 Global Penpulimab Injection Market Size Forecast by Region
  12.1.1 Global Penpulimab Injection Forecast by Region (2025-2030)
  12.1.2 Global Penpulimab Injection Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Penpulimab Injection Forecast by Type (2025-2030)
12.7 Global Penpulimab Injection Forecast by Application (2025-2030)

13 KEY PLAYERS ANALYSIS

13.1 Akeso, Inc
  13.1.1 Akeso, Inc Company Information
  13.1.2 Akeso, Inc Penpulimab Injection Product Portfolios and Specifications
  13.1.3 Akeso, Inc Penpulimab Injection Sales, Revenue, Price and Gross Margin (2019-2024)
  13.1.4 Akeso, Inc Main Business Overview
  13.1.5 Akeso, Inc Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION


LIST OFTABLES

Table 1. Penpulimab Injection Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Penpulimab Injection Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of 100mg (10mL)/Bottle
Table 4. Major Players of Other
Table 5. Global Penpulimab Injection Sales byType (2019-2024) & (K Units)
Table 6. Global Penpulimab Injection Sales Market Share byType (2019-2024)
Table 7. Global Penpulimab Injection Revenue byType (2019-2024) & ($ million)
Table 8. Global Penpulimab Injection Revenue Market Share byType (2019-2024)
Table 9. Global Penpulimab Injection Sale Price byType (2019-2024) & (US$/Unit)
Table 10. Global Penpulimab Injection Sale by Application (2019-2024) & (K Units)
Table 11. Global Penpulimab Injection Sale Market Share by Application (2019-2024)
Table 12. Global Penpulimab Injection Revenue by Application (2019-2024) & ($ million)
Table 13. Global Penpulimab Injection Revenue Market Share by Application (2019-2024)
Table 14. Global Penpulimab Injection Sale Price by Application (2019-2024) & (US$/Unit)
Table 15. Global Penpulimab Injection Sales by Company (2019-2024) & (K Units)
Table 16. Global Penpulimab Injection Sales Market Share by Company (2019-2024)
Table 17. Global Penpulimab Injection Revenue by Company (2019-2024) & ($ millions)
Table 18. Global Penpulimab Injection Revenue Market Share by Company (2019-2024)
Table 19. Global Penpulimab Injection Sale Price by Company (2019-2024) & (US$/Unit)
Table 20. Key Manufacturers Penpulimab Injection Producing Area Distribution and Sales Area
Table 21. Players Penpulimab Injection Products Offered
Table 22. Penpulimab Injection Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Penpulimab Injection Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Penpulimab Injection Sales Market Share Geographic Region (2019-2024)
Table 27. Global Penpulimab Injection Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Penpulimab Injection Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Penpulimab Injection Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Penpulimab Injection Sales Market Share by Country/Region (2019-2024)
Table 31. Global Penpulimab Injection Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Penpulimab Injection Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Penpulimab Injection Sales by Country (2019-2024) & (K Units)
Table 34. Americas Penpulimab Injection Sales Market Share by Country (2019-2024)
Table 35. Americas Penpulimab Injection Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas Penpulimab Injection Sales byType (2019-2024) & (K Units)
Table 37. Americas Penpulimab Injection Sales by Application (2019-2024) & (K Units)
Table 38. APAC Penpulimab Injection Sales by Region (2019-2024) & (K Units)
Table 39. APAC Penpulimab Injection Sales Market Share by Region (2019-2024)
Table 40. APAC Penpulimab Injection Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC Penpulimab Injection Sales byType (2019-2024) & (K Units)
Table 42. APAC Penpulimab Injection Sales by Application (2019-2024) & (K Units)
Table 43. Europe Penpulimab Injection Sales by Country (2019-2024) & (K Units)
Table 44. Europe Penpulimab Injection Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe Penpulimab Injection Sales byType (2019-2024) & (K Units)
Table 46. Europe Penpulimab Injection Sales by Application (2019-2024) & (K Units)
Table 47. Middle East & Africa Penpulimab Injection Sales by Country (2019-2024) & (K Units)
Table 48. Middle East & Africa Penpulimab Injection Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa Penpulimab Injection Sales byType (2019-2024) & (K Units)
Table 50. Middle East & Africa Penpulimab Injection Sales by Application (2019-2024) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Penpulimab Injection
Table 52. Key Market Challenges & Risks of Penpulimab Injection
Table 53. Key IndustryTrends of Penpulimab Injection
Table 54. Penpulimab Injection Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Penpulimab Injection Distributors List
Table 57. Penpulimab Injection Customer List
Table 58. Global Penpulimab Injection SalesForecast by Region (2025-2030) & (K Units)
Table 59. Global Penpulimab Injection RevenueForecast by Region (2025-2030) & ($ millions)
Table 60. Americas Penpulimab Injection SalesForecast by Country (2025-2030) & (K Units)
Table 61. Americas Penpulimab Injection Annual RevenueForecast by Country (2025-2030) & ($ millions)
Table 62. APAC Penpulimab Injection SalesForecast by Region (2025-2030) & (K Units)
Table 63. APAC Penpulimab Injection Annual RevenueForecast by Region (2025-2030) & ($ millions)
Table 64. Europe Penpulimab Injection SalesForecast by Country (2025-2030) & (K Units)
Table 65. Europe Penpulimab Injection RevenueForecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa Penpulimab Injection SalesForecast by Country (2025-2030) & (K Units)
Table 67. Middle East & Africa Penpulimab Injection RevenueForecast by Country (2025-2030) & ($ millions)
Table 68. Global Penpulimab Injection SalesForecast byType (2025-2030) & (K Units)
Table 69. Global Penpulimab Injection RevenueForecast byType (2025-2030) & ($ millions)
Table 70. Global Penpulimab Injection SalesForecast by Application (2025-2030) & (K Units)
Table 71. Global Penpulimab Injection RevenueForecast by Application (2025-2030) & ($ millions)
Table 72. Akeso, Inc Basic Information, Penpulimab Injection Manufacturing Base, Sales Area and Its Competitors
Table 73. Akeso, Inc Penpulimab Injection Product Portfolios and Specifications
Table 74. Akeso, Inc Penpulimab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Akeso, Inc Main Business
Table 76. Akeso, Inc Latest Developments



LIST OFFIGURES

Figure 1. Picture of Penpulimab Injection
Figure 2. Penpulimab Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Penpulimab Injection Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Penpulimab Injection Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Penpulimab Injection Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Penpulimab Injection Sales Market Share by Country/Region (2023)
Figure 10. Penpulimab Injection Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of 100mg (10mL)/Bottle
Figure 12. Product Picture of Other
Figure 13. Global Penpulimab Injection Sales Market Share byType in 2023
Figure 14. Global Penpulimab Injection Revenue Market Share byType (2019-2024)
Figure 15. Penpulimab Injection Consumed in Lung Cancer
Figure 16. Global Penpulimab Injection Market: Lung Cancer (2019-2024) & (K Units)
Figure 17. Penpulimab Injection Consumed in Lymphoma
Figure 18. Global Penpulimab Injection Market: Lymphoma (2019-2024) & (K Units)
Figure 19. Penpulimab Injection Consumed in Nasopharyngeal Carcinoma
Figure 20. Global Penpulimab Injection Market: Nasopharyngeal Carcinoma (2019-2024) & (K Units)
Figure 21. Penpulimab Injection Consumed in Liver Cancer
Figure 22. Global Penpulimab Injection Market: Liver Cancer (2019-2024) & (K Units)
Figure 23. Penpulimab Injection Consumed in Gastric Cancer
Figure 24. Global Penpulimab Injection Market: Gastric Cancer (2019-2024) & (K Units)
Figure 25. Global Penpulimab Injection Sale Market Share by Application (2023)
Figure 26. Global Penpulimab Injection Revenue Market Share by Application in 2023
Figure 27. Penpulimab Injection Sales by Company in 2023 (K Units)
Figure 28. Global Penpulimab Injection Sales Market Share by Company in 2023
Figure 29. Penpulimab Injection Revenue by Company in 2023 ($ millions)
Figure 30. Global Penpulimab Injection Revenue Market Share by Company in 2023
Figure 31. Global Penpulimab Injection Sales Market Share by Geographic Region (2019-2024)
Figure 32. Global Penpulimab Injection Revenue Market Share by Geographic Region in 2023
Figure 33. Americas Penpulimab Injection Sales 2019-2024 (K Units)
Figure 34. Americas Penpulimab Injection Revenue 2019-2024 ($ millions)
Figure 35. APAC Penpulimab Injection Sales 2019-2024 (K Units)
Figure 36. APAC Penpulimab Injection Revenue 2019-2024 ($ millions)
Figure 37. Europe Penpulimab Injection Sales 2019-2024 (K Units)
Figure 38. Europe Penpulimab Injection Revenue 2019-2024 ($ millions)
Figure 39. Middle East & Africa Penpulimab Injection Sales 2019-2024 (K Units)
Figure 40. Middle East & Africa Penpulimab Injection Revenue 2019-2024 ($ millions)
Figure 41. Americas Penpulimab Injection Sales Market Share by Country in 2023
Figure 42. Americas Penpulimab Injection Revenue Market Share by Country (2019-2024)
Figure 43. Americas Penpulimab Injection Sales Market Share byType (2019-2024)
Figure 44. Americas Penpulimab Injection Sales Market Share by Application (2019-2024)
Figure 45. United States Penpulimab Injection Revenue Growth 2019-2024 ($ millions)
Figure 46. Canada Penpulimab Injection Revenue Growth 2019-2024 ($ millions)
Figure 47. Mexico Penpulimab Injection Revenue Growth 2019-2024 ($ millions)
Figure 48. Brazil Penpulimab Injection Revenue Growth 2019-2024 ($ millions)
Figure 49. APAC Penpulimab Injection Sales Market Share by Region in 2023
Figure 50. APAC Penpulimab Injection Revenue Market Share by Region (2019-2024)
Figure 51. APAC Penpulimab Injection Sales Market Share byType (2019-2024)
Figure 52. APAC Penpulimab Injection Sales Market Share by Application (2019-2024)
Figure 53. China Penpulimab Injection Revenue Growth 2019-2024 ($ millions)
Figure 54. Japan Penpulimab Injection Revenue Growth 2019-2024 ($ millions)
Figure 55. South Korea Penpulimab Injection Revenue Growth 2019-2024 ($ millions)
Figure 56. Southeast Asia Penpulimab Injection Revenue Growth 2019-2024 ($ millions)
Figure 57. India Penpulimab Injection Revenue Growth 2019-2024 ($ millions)
Figure 58. Australia Penpulimab Injection Revenue Growth 2019-2024 ($ millions)
Figure 59. ChinaTaiwan Penpulimab Injection Revenue Growth 2019-2024 ($ millions)
Figure 60. Europe Penpulimab Injection Sales Market Share by Country in 2023
Figure 61. Europe Penpulimab Injection Revenue Market Share by Country (2019-2024)
Figure 62. Europe Penpulimab Injection Sales Market Share byType (2019-2024)
Figure 63. Europe Penpulimab Injection Sales Market Share by Application (2019-2024)
Figure 64. Germany Penpulimab Injection Revenue Growth 2019-2024 ($ millions)
Figure 65.France Penpulimab Injection Revenue Growth 2019-2024 ($ millions)
Figure 66. UK Penpulimab Injection Revenue Growth 2019-2024 ($ millions)
Figure 67. Italy Penpulimab Injection Revenue Growth 2019-2024 ($ millions)
Figure 68. Russia Penpulimab Injection Revenue Growth 2019-2024 ($ millions)
Figure 69. Middle East & Africa Penpulimab Injection Sales Market Share by Country (2019-2024)
Figure 70. Middle East & Africa Penpulimab Injection Sales Market Share byType (2019-2024)
Figure 71. Middle East & Africa Penpulimab Injection Sales Market Share by Application (2019-2024)
Figure 72. Egypt Penpulimab Injection Revenue Growth 2019-2024 ($ millions)
Figure 73. South Africa Penpulimab Injection Revenue Growth 2019-2024 ($ millions)
Figure 74. Israel Penpulimab Injection Revenue Growth 2019-2024 ($ millions)
Figure 75.Turkey Penpulimab Injection Revenue Growth 2019-2024 ($ millions)
Figure 76. GCC Countries Penpulimab Injection Revenue Growth 2019-2024 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Penpulimab Injection in 2023
Figure 78. Manufacturing Process Analysis of Penpulimab Injection
Figure 79. Industry Chain Structure of Penpulimab Injection
Figure 80. Channels of Distribution
Figure 81. Global Penpulimab Injection Sales MarketForecast by Region (2025-2030)
Figure 82. Global Penpulimab Injection Revenue Market ShareForecast by Region (2025-2030)
Figure 83. Global Penpulimab Injection Sales Market ShareForecast byType (2025-2030)
Figure 84. Global Penpulimab Injection Revenue Market ShareForecast byType (2025-2030)
Figure 85. Global Penpulimab Injection Sales Market ShareForecast by Application (2025-2030)
Figure 86. Global Penpulimab Injection Revenue Market ShareForecast by Application (2025-2030)